QuickView for Transferrin receptor-like, dimerisation domain (biogroup)

1. Inflammatory bowel disease before and after first infliximab treatment
2. Neural development of iPSCs derived from Autistic patients with BCKD-kinase mutations
3. Adipose tissue, adipocytes and stromal-vascular pellet cells from multiple body regions
4. Prostate cancer metastases to different sites characterized by AR, CHGA, ERG and SYP markers
5. Prostate cancer cells, normal epithelial and stroma cells treated with Vitamin E or Selenium

There were no matches for Transferrin receptor-like, dimerisation domain

There were no clinical trials for Transferrin receptor-like, dimerisation domain